Literature DB >> 12412933

Laboratory cross-contamination of Mycobacterium tuberculosis: an investigation and analysis of causes and consequences.

M Poynten1, D N Andresen, T Gottlieb.   

Abstract

BACKGROUND: The misdiagnosis of Mycobacterium tuberculosis infection has many ramifications. These include medical and psychological implications for patients and their families and financial and public health implications for health-care institutions. Microbiology laboratory procedures should minimize the possibility of laboratory cross-contamination of specimens and maximize the ability to recognize a cluster of false-positive cultures. Newer molecular typing methods provide rapid, accurate and effective means of identifying false-positive M. tuberculosis cultures. AIMS: To investigate a cluster of patients with positive M. tuberculosis cultures that were processed in the mycobacteriology laboratory on the same day.
METHODS: Five patients' medical records and radiology results were reviewed to determine whether the cases were epidemiologically linked and whether there was clinical suspicion of tuberculosis. Restriction fragment length polymorphism (DNA fingerprinting) was performed using repetitive elements IS6110 and pTBN12. Laboratory processing procedures were analysed.
RESULTS: On the basis of DNA fingerprinting using IS6110, the isolates from all five patients were identical. Molecular typing using pTBN12 was performed on four of the five isolates. All four had identical patterns. There was no epidemiological link between the patients. At least three (and probably four) of the five patients were misdiagnosed with tuberculosis.
CONCLUSION: Microbiology laboratories should ensure that appropriate methodologies are in place to avoid cross-contamination of specimens. Clinicians need to critically interpret any positive laboratory result, especially in an unlikely clinical setting.

Entities:  

Mesh:

Year:  2002        PMID: 12412933     DOI: 10.1046/j.1445-5994.2002.00271.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  6 in total

1.  Impact of laboratory cross-contamination on molecular epidemiology studies of tuberculosis.

Authors:  Miguel Martínez; Darío García de Viedma; María Alonso; Sandra Andrés; Emilio Bouza; Teresa Cabezas; Isabel Cabeza; Armando Reyes; Waldo Sánchez-Yebra; Manuel Rodríguez; M Isabel Sánchez; M Cruz Rogado; Rosa Fernández; Teresa Peñafiel; Juan Martínez; Pilar Barroso; M Angeles Lucerna; L Felipe Diez; Carmelo Gutiérrez
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

2.  Qualitative Analysis To Ascertain Genotypic Identity of or Differences between Mycobacterium tuberculosis Isolates in Laboratories with Limited Resources.

Authors:  Fernanda Sislema-Egas; María Jesús Ruiz-Serrano; Emilio Bouza; Darío García-de-Viedma
Journal:  J Clin Microbiol       Date:  2013-10-02       Impact factor: 5.948

3.  False-positive tuberculous meningitis due to laboratory contamination: importance of a holistic clinical evaluation.

Authors:  Saraschandra Vallabhajosyula; Renuga Vivekanandan; Edward A Horowitz
Journal:  BMJ Case Rep       Date:  2014-05-21

4.  The realistic performance achievable with mycobacterial automated culture systems in high and low prevalence settings.

Authors:  Sanne C van Kampen; Richard M Anthony; Paul R Klatser
Journal:  BMC Infect Dis       Date:  2010-04-12       Impact factor: 3.090

5.  Infrequent MODS TB culture cross-contamination in a high-burden resource-poor setting.

Authors:  David A J Moore; Luz Caviedes; Robert H Gilman; Jorge Coronel; Fanny Arenas; Doris LaChira; Cayo Salazar; Juan Carlos Saravia; Richard A Oberhelman; Maria-Graciela Hollm-Delgado; A Roderick Escombe; Carlton A W Evans; Jon S Friedland
Journal:  Diagn Microbiol Infect Dis       Date:  2006-05-06       Impact factor: 2.803

Review 6.  Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.

Authors:  Betty A Forbes; Geraldine S Hall; Melissa B Miller; Susan M Novak; Marie-Claire Rowlinson; Max Salfinger; Akos Somoskövi; David M Warshauer; Michael L Wilson
Journal:  Clin Microbiol Rev       Date:  2018-01-31       Impact factor: 26.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.